iMicroQ

iMICROQ participates in the IV Poultry Health Course

diego — Fri, 10 May 2013 10:34:44 +0000

The 22nd and 23rd May it will be celebrated the IV Poultry Health Course organized by the Centro de Calidad Avícola y Alimentación Animal de la Comunidad de Valencia (CECAV) and the Universidad CEU Cardenal Herrera.

iMICROQ participates in the Course making a presentation entitled “Fast Salmonella determination method” and presenting the QFast Salmonella Kit.

The fourth edition of the Poultry Health Course is focused on Diagnosis and Prevention tools. During the course were held conferences on quality systems, diagnostics, epidemiology and environmental control. Also it will be conducted workshops on poultry necropsies and embriodiagnostics.

More informacion about the course

iMICROQ & LAYMATEC sign a distribution agreement of QFast in emerging countries

diego — Thu, 09 May 2013 09:33:36 +0000

iMICROQ & LAYMATEC have signed an agreement whereby Laymatec, given his experience in international markets, will distribute QFast platform in emerging countries.

The agreement is based on the distribution, sale and technical support of QFast detection and identification system of pathogenic agents in emerging countries.

The sectors considered in this agreement are poultry industry, cosmetics, pulp and paper, raw materials, food processing and water.

Initially, target countries of this agreement, with significant growth potential, are:

• Russia
• Kazakhstan
• Turkey
• Middle East (Saudi Arabia, United Arab Emirates, Egypt)
• Morocco

iMICROQ and LAYMATEC have signed a collaboration agreement

diego — Wed, 08 May 2013 08:51:38 +0000

iMICROQ and LAYMATEC are working together on different projects mainly oriented on R&D projects oriented to give complementary solutions of common interest in the area of physical-chemical and microbiological analysis, especially in poultry, cosmetics, pulp and paper, raw materials, food processing and water.

Both companies have signed a collaboration agreement for microbiology analytical services and physical-chemical parameters, with the resources and infrastructure of LAYMATEC in geographical areas where iMicroQ operates directly. Thus, iMicroQ expands its portfolio of services to offer to its customers a comprehensive analytical service using QFAST platform and offering the traditional analytical method.

In a complementary manner, the agreement includes analytical services of physicochemical parameters for other projects that require solutions “tailored” to meet the needs and challenges that each iMicroQ client may have.

iMICROQ achieves an investment agreement to fund the industrialization and commercialization of the Kit QFast Salmonella

diego — Fri, 03 May 2013 08:18:44 +0000

On April 17, 2013, iMICROQ signed the new associate agreement and capital increase to finance the development of its business.

”la Caixa”, through its venture capital agency, Caixa Capital Risc, has led an investment of 1.1 million euros in iMICROQ. The financial entity has made the investment thought its fund specialized in biotechnology and medical technologies, Caixa Capital BioMed.

In addition, a group of business angels with experience in international business development have joined the investment round.

This round of investment is aimed for accelerating international validation activities, industrial and production tests to start the international commercialization of the kit for rapid detection of Salmonella spp (QFast Salmonella).

More information

iMICROQ participates in JPA 2013

diego — Mon, 15 Apr 2013 09:32:25 +0000

iMICROQ participates in the Jornadas Profesionales de Avicultura (JPA 2013) organized by the Real Escuela de Avicultura in Leon from 28th to 31st May.

The congress is divided into four blocks, differentiating between poultry production and egg-laying. It will be covered different topics such as nutrition, pathology, reproduction and incubation, sustainable production systems, industry-specific issues and trends on the welfare of poultry.

In the course of the congress, iMICROQ will made a presentation entitled “Innovation in diagnostic techniques. A revolutionary approach of farm-level diagnostic: analytical micro-technology for recognition of poultry pathogen bacterial microorganisms”.

iMICROQ visits FIGAN 2013

diego — Thu, 21 Mar 2013 08:37:41 +0000

iMicroQ has visited the Salón Internacional de Producción Ganadera (FIGAN) 2013, where major international agricultural companies presented the latest technological innovations and business solutions designed to enhance the development of livestock activities and face the future of the market and industry.

A total of 836 exhibitors from twenty-five countries presented their latest developments in the eleventh edition of the Feria Internacional de la Producción Animal, that takes place from 19th to 22nd March.

The iMICROQ delegation has visited FIGAN exhibitors presenting the future market launch of the QFast Salmonella Kit, that allows an easy, fast and reliable determination of the presence or absence of Salmonella spp in primary production environments, environmental samples, eggs, meat products, animal feed and raw materials.

IMICROQ awarded with the 1st Opinno Biotech Competition

manolo — Thu, 27 Oct 2011 13:19:26 +0000

IMICROQ won the 1^st edition of the Competition Opinno Biotech. It has also taken part as a participating company in the Investment Forum, organized in partnership with MIT Enterprise Forum. This Forum has brought together prominent business projects and a select group of venture capital investors specialised in green technologies, biotechnology / nanotechnology, as well as information and communication technologies.

EmTech is the biggest event of the Annual Technology Review, the most prestigious publication of the Massachusetts Institute of Technology (MIT). For the first time, this meeting, held for 12 years in Boston, had a replica in Europe. EmTech Spain arrives to Spain (26-27 October, Malaga), to bring together business leaders, the most important researchers and technologists, as well as the most innovative entrepreneurs to share knowledge.

Within the framework of the MIT conference EmTech Spain, innovative ideas and important projects of young Spanish scientists have been awarded through the Opinno Biotech Competition sponsored by Genome Spain and Zeltia. Thus, this competition has selected the works that have develop new technologies or new applications for existing technologies, and that represent an advance in the field of biotechnology. In addition, all participants have benefited from an Elevator Pitch to a wide number of investors, MIT academics, trend leaders, media, etc..
The selected projects have been 25 in total, of which 5 have been finalists:

AlphaSip: company expert in the development of medical diagnostic chips, focusing its technology in the fields of haematology and cardiovascular disease. The company’s main landmark is a home-used monitoring device oriented to patients treated with oral anticoagulants.
Ambiox Biotech: spin-off from the University of Alcala de Henares and the Gregorio Marañón Hospital in Madrid. It specializes in nanotechnology innovation and its application in the biomedicine field. Its present main objective is to stop the impact of AIDS on society with a topical gel.
Biotech Hesperides Group S.L: first EBT at the University Pablo de Olavide. It focuses on developing innovative food and beverage from biotechnological transformation of fruits, juices, milk, etc.
IMICROQ, Integrated Microsystems for Quality of Life S.L.
MicruX: start-up focused on the development and commercialization of microchip capillary electrophoresis (based on lab-on-a-Chip technology), as well as instrumentation and applications for different sectors of society.

Finalist Company of the 1st edition of the Competition Opinno Biotech, October 2011

manolo — Wed, 26 Oct 2011 13:46:16 +0000

EmTech is the big event of the annual Technology Review, the most prestigious publication of the Massachusetts Institute of Technology (MIT). For the first time, this meeting, held for 12 years in Boston, has a replica in Europe. EmTech Spain arrives to Spain, 26-27 October in Malaga, to bring together business leaders, the most important researchers and technologists, as well as the most innovative entrepreneurs to share knowledge.

Within the framework of the MIT conference EmTech Spain, through the Opinno Biotech Competition, innovative ideas and important projects of young Spanish scientists have been awarded. Thus, this competition has selected the works that have develop new technologies or new applications for existing technologies, and that represent an advance in the field of biotechnology.

IMICROQ has been a finalist company in this 1^st edition of the Competition Opinno Biotech. It has also debuted as a participating company in the Investment Forum, organized in partnership with MIT Enterprise Forum. This Forum has brought together prominent business projects and a select group of venture capital investor specializing in green technologies, biotechnology / nanotechnology, as well as information and communication technologies.

Protected: Seminar: Control of salmonella

manolo — Wed, 29 Jun 2011 16:42:57 +0000

Gallery: Control of Salmonella

carlos — Fri, 27 May 2011 10:45:41 +0000

The 22^nd of June 2011 took place the technical workshop “Control of Salmonella: future prospects: legislation and analytical techniques” organized by IMICROQ, the Aragon and Catalonia Aviary Sanitary Centre (CESAC) and the Research Centre ATIC, University Rovira i Virgili. This event was sponsored by ACC10, Agency for the Support of the Competitiveness of the Catalan Business; ITPSA S.A.: HIPRA; S.P. Veterinary S.A. Adiveter S.L.; ESTEVE Pharmaceutical Group; Anorsa S.A. y Scharlab S.L.